NCT04884035 2026-04-17Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat LymphomaCelgenePhase 1 Recruiting224 enrolled
NCT06015880 2026-04-16Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Recruiting30 enrolled